Pharmaceutical Industry

Is the
current model fit for purpose?

These are symptoms of a decline of the pre-digital era model of medicinal product development. Our pharmaceutical industry members are those who are committed to moderninsing their product development to create safer and more effective medicinal products. 

Modernisation of the pharmaceutical industry requires a coresponding moderninsation of the way in which medicinal products are brought on to the market and the design of clinical trials. The Avicenna Alliance is working to promote modelling and simulation as a means of addressing the high cost of research and the uptake of in silico methods.

Avicenna Alliance news

The Commission adopted a Communication on a new European Research Area for Research and Innovation

On 30 September the European Commission adopted a Communication on a new European Research Area for...

find out more ›

CADFEM Medical ONLINE Conference 2020

Under the motto "in vivo, in vitro, in silico - the central role of in silico medicine - what it can do and what we need for it", this year's specialist...

find out more ›

Avicenna provides feedback to the survey on the pharmaceutical strategy

On 15 September the Avicenna Alliance submitted Member's feedback to the survey on the pharmaceutical strategy! While...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up